PKM2 inhibition may reverse therapeutic resistance to transarterial chemoembolization in hepatocellular carcinoma
Sean P. Martin(National Cancer Institute), Xin Wei Wang(National Cancer Institute)
Cited by 99
Related Papers
Cancer stem cells in the development of liver cancer
|Journal of Clinical Investigation|2013|524
Tumor methionine metabolism drives T-cell exhaustion in hepatocellular carcinoma
|Nature Communications|2021|234
Multiregional single-cell dissection of tumor and immune cells reveals stable lock-and-key features in liver cancer
|Nature Communications|2022|156
Three-dimensional Organotypic Culture Models of Human Hepatocellular Carcinoma
|Scientific Reports|2016|84